Skip to main content
Premium Trial:

Request an Annual Quote

Baron Frederick Charles von Nidda, John Newton

Premium

DNA-security company Applied DNA Sciences this week said it has opened a marketing and sales office in London, and appointed

Baron Frederick Charles von Nidda

as general manager.

Von Nidda, a partner in the European-advisory firm GA Associates, has recently helped with the finance and expansion of a number of independent businesses, including the engineering firm Minimould, the pharma company Res-Del International, the medical firm Clinical Research Centres International; and the media concern Tri-Continental Films.


Gene Logic of Gaithersburg, Md., today announced the completion of its $52 million acquisition of TherImmune Research.

Gene Logic paid TherImmune shareholders approximately $30.9 million in cash, and issued 4 million shares of common stock, with a value of approximately $21.2 million, based on the closing price of its stock.

The company announced the acquisition in February.


The UK Biobank has appointed as CEO John Newton, a consultant in epidemiology at University of Oxford’s unit of health care epidemiology.

The UK Biobank funders are composed of the Medical Research Council, the Wellcome Trust, and the UK Department of Health.

Filed under

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.